Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot ...

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

The CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger than 8 months receiving clesrovimab (Enflonsia) to prevent respiratory ...

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

Citing Indian Council for Medical Research (ICMR) and published studies, Dr Bhavesh Kotak, Head of Medical Affairs at Dr ...